Do not waste time, Download free COG-300 cheat sheets and Practice Questions

Move through our COG-300 Queries answers and feel Certified the COG-300 examination. You will move your COG-300 test on high marks or even your cashback. We all have aggregated the database of COG-300 practice questions through the actual test in order to be able in order to provide you along with prep in order to get equipped plus pass COG-300 test on the first attempt. Merely install our VCE Exam Simulator plus obtain ready. A person will pass the particular IBM Cognos TM1 Analyst exam.

Exam Code: COG-300 Practice exam 2023 by Killexams.com team
IBM Cognos TM1 Analyst
Cognos Analyst outline
Killexams : Cognos Analyst outline - BingNews https://killexams.com/pass4sure/exam-detail/COG-300 Search results Killexams : Cognos Analyst outline - BingNews https://killexams.com/pass4sure/exam-detail/COG-300 https://killexams.com/exam_list/Cognos Killexams : Cognos Access & Resources

Cognos is a web-based suite of tools from IBM that offers a full range of business intelligence (BI) capabilities including reports, analysis, dashboards, scorecards, mobile BI and more.  Cognos is Purdue’s primary Business Intelligence(BI) tool and is used to access many of the university’s BI environments including those to access student-related data.

Go to Cognos

Cognos is the system Purdue uses for official reporting on Purdue student data. If you’d like to learn about how to request Cognos access, please visit the Business Intelligence Competency Center Website.

Helpful Resources

Sat, 16 Jul 2022 07:12:00 -0500 en-US text/html https://www.purdue.edu/enrollmentmanagement/data-reports/cognos/
Killexams : About Cognos

Cognos is a web-based suite of tools from IBM that offers a full range of business intelligence capabilities including reports, analysis, dashboards, scorecards, mobile BI and more.  Cognos is Purdue's primary BI tool and is used to access many of the university's BI environments including Student ODS/EDW, the Finance and HR data marts, and GM AIMS.

Cognos Licensing levels are as follows:

  • Consumer - users are licensed to consume existing or standard reports as needed using the Cognos web portal.  Users with this license generally consume existing reports to complete their daily tasks and are not required to know the data at a detailed level.  Basic data training is required for this role.
  • Authoring - the report writing tool used to build reports.

Access

For student data, see the Student ODS/EDW access page for steps on requesting access.

For business data, see the HR/FI access page for steps on requesting access.

For additional help within Cognos after gaining access, review the Cognos Resources page for additional information for all Cognos users.

Maintenance Window

The standard Cognos maintenance window is Saturdays from 3:45PM to midnight. Additional outages will be communicated.

Wed, 13 Jun 2018 21:17:00 -0500 en text/html https://www.purdue.edu/bicc/tools/cognos/index.php
Killexams : Cognos Reporting Tools

The following Cognos system reports (login required) are recommended by Accounting Services for Research and Sponsored Programs (ASRSP) for administrators to use when monitoring their unit's sponsored projects.

GM044 - Sponsored Project Portfolio

  • This report displays balances for active projects including totals for direct and indirect expenditures as well as encumbrances by department and/or principal investigator

  • It can run for negative balances only to monitor deficit spending

  • Drill through available by project to the GM045 - Sponsored Project Budget Statement

GM086 - Projects Balances Report

  • Similar to Sponsored Project Portfolio, but with added data fields including ASRSP Grant and Contract Financial Administrator (GCFA) Name, Award ID/Sponsor ID, Start and End dates
  • No drill through capability
  • Recommended by ASRSP: run for current period, all Contract Statuses, Active Projects, and specify either a particular PI for Manager/Reviewer field or select particular department for a detailed view of the current financial status of your constituency. View in Excel 2007 Data file type.

GM045 - Sponsored Project Budget Statement

  • Displays direct and indirect expenditure totals by project against the total budget amount along with project demographic data

  • Dollars are broken out and shown by Current Accounting Period, Fiscal Year to Date, and Inception to Date

GM047 - Milestone (Deliverable) Report

  • Used by department administrators and PIs in tracking upcoming deliverable due dates to assist in meeting sponsor and institutional requirements

GM091 - Sponsor Payments Received

  • Presents details of payments received by contract, with a breakout by project
  • Payment activity includes all forms of payments as well as a subset of write-offs and other maintenance items
  • Note: For converted non-clinical awards, payment data prior to December 2008 is not available

GM092 - Subcontract Monitoring Report

  • Displays a complete list of fully-executed subcontracts
  • Current status for funding and disbursement
  • Includes the burn rates (percent disbursed)

GM093 - Cost Share Commitment Status

  • Presents revenue and expense data from NUFinancials Commitment Control for sponsored projects with cost sharing
  • Grants users a multi-year view of budget, revenue and expense on cost share funds
  • Provides a comprehensive view of all departments committing cost share funds to a given sponsored project

GM096 - Grants Transaction History Queries

  • Displays expense and budget transactions on sponsored (grant) chart strings. This report, when downloaded to Excel, can be used in conjunction with ASRSP’s Expense Review Workbook template. The report contains two sections, “Expense Transaction Query” and “Budget Query”. When exported to Excel, the data will appear on separate tabs.
  • This report is used by Principal Investigators, Department Administrators, and ASRSP to review detailed transaction history by contract or project id. It can reduce compliance risk by providing departments with easier access to and greater detail regarding expenses posted to grants.

GM097- Sponsored Project Actuals Balance Report

  • GM097 Guide to Understanding
  • GM097 ASRSP Formatting Recommendations
  • The GM097 displays a comprehensive view of a research departments' entire research project portfolio, including non-clinical sponsored projects, cost-shared projects, and clinical trials.
  • Non-clinical project balances are displayed Total Budget less Direct and F&A Expenditures and Encumbrances.
  • Clinical project balances are displayed Cash Received less Direct and F&A Expenditures and Encumbrances, with Protocol numbers.

GL008 - Revenue and Expense Activity Report

SC016 - Open Encumbrances Report

GL069 - Financial Summary

Fri, 02 Sep 2022 09:25:00 -0500 en text/html https://www.northwestern.edu/asrsp/grant-management/cognos-reporting-tools.html
Killexams : Guide to analyst recommendations

Guide to analyst recommendations

The following is a guide to the stock-research ratings systems used by the brokerage firms covered by MarketWatch.

Because ratings terms vary from firm to firm, the guide is designed to help investors understand the meaning behind each rating (where available) and to allow them to make comparisons between each firm's recommendation. Some brokerages turned down MarketWatch's requests for their rating descriptions.

For analysts' current ratings changes and other research click here.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | W | Y

A.G. Edwards

  • Buy
    A total return is anticipated in excess of the market's long-term historic annual rate (approximately 10%). Total return expectations should be higher for stocks that possess greater risk.
  • Hold
    Hold the shares with neither a materially positive total return nor a materially negative total return anticipated.
  • Sell
    Stock should be sold as materially negative total return is anticipated.

Advanced Equities

Has both short-term and long-term rating for each stock

  • Strong Buy
  • Buy
  • Accumulate
  • Neutral

Advest

  • Strong Buy
  • Buy
  • Market Perform
  • Market Underperform

BB&T Capital Markets

  • Strong Buy
    Estimated total return potential greater than or equal to 25 percent.
  • Long-Term Buy
    Estimated total return potential greater than or equal to 10 percent and less than 25 percent.
  • Hold
    Estimated total return potential greater than or equal to 0 percent and less than 10 percent.
  • Underweight
    Estimated total return potential less than 0 percent.

BMO Nesbitt Burns

  • Top Pick
  • Buy
  • Outperform
  • Market Perform
  • Underperform

Banc of America Securities

  • Strong Buy
  • Buy
  • Market Performer
  • Underperformer

Barrington Research

  • Strong Buy
    Expected to outperform the market over the next six months. Potential exists for near-term catalyst
  • Accumulate
    Expected to outperform the market over the next 12 months. Suggest establishing partial positions at current levels, adding on price weakness or improved fundamentals.
  • Market Perform
    Expected to underperform the market over next six months. Fully valued or overvalued at current levels.
  • Sell
    Expected to significantly underperform the market. Deteriorating fundamentals

Bear Stearns

  • Outperform
    Stock is projected to outperform the analyst's coverage universe over next 12 months.
  • Peer Perform
    Stock is projected to perform approximately in line with analyst's industry coverage universe over next 12 months.
  • Underperform
    Stock is projected to underperform the analyst's industry coverage universe over the next 12-months.

Sectors are also rated either Market Overweight, Market Weight and Market Underweight.

Belmont Harbor Capital

  • Outperformer -Intermediate-term (up to 6 months)
    Common stock expected to provide total return that is 5 or more percentage points greater than S&P 500; Long-term (6-18 months) - Common stock expected to provide total return that is at least 10 percentage points greater than S&P 500
  • Market Performer -Intermediate-term
    Common stock expected to provide total return within 4 percentage points (plus/minus) than S&P 500; Long-term - Common stock is expected to provide total return that is within 9 percentage points (plus/minus) than S&P 500
  • Underperformer -Intermediate-term
    Common stock is expected to provide total return that is 5 or more percentage points less than S&P 500; Long-term - Common stock is expected to provide total return that is at least 10 percentage points less than S&P 500

Blaylock & Partners

  • Buy
    Expects stock to outperform the generally recognized market indexes by 20 percent
  • Hold
    Expects stock to track generally recognized market indexes
  • Sell
    Expects stock to underperform generally recognized market indexes by 20 percent
  • Not Rated
    An investment banking client that has generated material fees over the past 12 months or who may pay fees in next 3 months

Brean Murray & Co.

  • Strong Buy
    Expected to outperform market over next 6-12 months, minimal risk to fundamentals or valuation. Good long-term investment.
  • Buy
    Expected to outperform the market over next 12 months; moderate risk to fundamentals or valuation.
  • Hold
    Expected to perform in line with the market over next 6-12 months, moderate to substantial risk to fundamentals or valuation.
  • Sell
    Expected to underperform the market over next 6-12 months, high risk to fundamentals or valuation.

Buckingham Research

  • Strong Buy
    Expects stock to appreciate 25% or more within next 6-12 months. There is good visibility and nearer-term earnings or events catalysts are expected.
  • Accumulate
    Expects 15-25% appreciation over next 6-12 months and stock is attractively valued but near-term catalysts are lacking.
  • Neutral
    Stock's current price reflects intermediate-term price objectives and expects stock to perform in line with the market.
  • Swap
    There appears to be more risk than reward in stock at current levels. Expects stock to underperform the market over next 6-12 months.

C.E. Unterberg Towbin

  • Short-Term Buy
    Over three to six months, estimated 20 percent appreciation
  • Long-Term Buy
    Over 12 to 24 months, estimated 35 percent appreciation
  • Short-Term Market Perform
    Performance in line with market averages anticipated over three to six months
  • Long-Term Market Perform
    Performance in line with market averages anticipated over 12 to 24 months
  • Short-Term Avoid
    Significant underperformance anticipated over three to six months
  • Long-Term Avoid
    Significant underperformance anticipated over 12 to 24 months

C.L. King

  • Strong Buy
    Projected relative performance of +20% or more in 12 months. Minimal risk to fundamentals, immediacy of story/catalysts in next 6 months.
  • Accumulate
    Projected relative performance of +10% or more in 12 months. Moderate risk to fundamentals, immediacy of story/catalysts in next 6-12 months.
  • Neutral
    Projected relative performance of +/-10% in 12 months. Moderate to substantial risk to fundamentals, immediacy of story/catalysts in next 6-12 months.
  • Sell
    Projected relative performance of -10% or more in 12 months. High risk to fundamentals, immediacy of story/catalysts in next 6 months.

CIBC World Markets

  • Sector Outperformer
    Stock expected to outperform sector during next 12-18 months.
  • Sector Performer
    Stock expected to perform in line with sector during next 12-18 months.
  • Sector Underperformer
    Stock expected to underperform sector during next 12-18 months.

Sectors carry weightings of overweight: Expected to outperform the broader market averages; market weight: Expected to equal performance of broader market averages; underweight: expected to underperform broader market averages.

CJS Securities

  • Strong Buy
  • Buy
  • Accumulate
  • Hold

Cohen Bros.

  • Strong Buy
    Stock projected to appreciate by more than 20 percent
  • Buy
    Stock projected to outperform the market
  • Hold
    Stock projected to perform in line with the market
  • Sell
    Stock projected to perform significantly below the market

Commerce Capital Markets

  • Strong Buy
    Expected to outperform market near-term and long-term by more than 10 percent
  • Market Outperform
    Expected to outperform market long-term by over 10 percent
  • Market Perform
    Expected to perform in-line with market (plus or minus 5 percent)
  • Market Underperform
    Expected to underperform market by more than 10 percent

Craig Hallum

  • Buy
    12-month or longer price target generally is at least 20% higher than current price.
  • Neutral
    12-month or longer price target generally is in a range of 19% higher to 10% lower than current price.
  • Sell
    12-month or longer price target generally is at least 10% below current price.

Credit Lyonnais

  • Buy
    Expected return above 20 percent over 12 months
  • Add
    Expected return between 10 and 20 percent over 12 months
  • Hold
    Expected return between 0 and 10 percent over 12 months
  • Reduce
    Expected negative return but by less than 20 percent over 12 months
  • Sell
    Expected negative return by more than 20 percent over 12 months

Credit Suisse First Boston

  • Outperform
    Stock's total return is expected to exceed the industry average by at least 10-15 percent (or more depending on perceived risk) over next 12 months.
  • Neutral
    Stock's toatal return is expected to be in line with the industry average (range of +/-10%) over next 12 months.
  • Underperform
    Stock's total return is expected to underperform the industry average by 10-15 percent or more over next 12 months.

Industries are rated either overweight: Expected to outperform the relevant broad market benchmark over the next 12 months; market weight: Expected to perform in-line with the relevant broad market benchmark over next 12 months; or underweight: Expected to underperform the relevant broad market benchmark over the next 12 months.

Davenport & Co.

  • Strong Buy
    Stocks are viewed as compelling short and long-term investment opportunities. Expects these shares to materially outperform the market over the next 12 months. Aggressive purchase is recommended at current levels.
  • Buy
    Shares offer attractive long-term appreciation potential from current prices. Would expect shares to outperform the market over a longer-term horizon and long-term investors can buy at current prices.
  • Neutral
    Shares should perform roughly in line with current market. Neither encourages purchase or sale of these securities at current prices.
  • Reduce/Sell
    Shares have more downside risk than upside potential at current prices. Expects shares to underperform the market from current prices.

Deutsche Bank Securities

  • Strong Buy
    Firm's best picks, backed with high degree of confidence. Expects significant outperformance against the market and the time to act to buy the stock is now.
  • Buy
    Stocks expected to outperform against the market by 10% or more over next 12 months.
  • Market Perform
    Relates to local index and indicates expectation stock will broadly perform in line with market over a 12-month period and that share price is likely to trade within a range of +/-10%.
  • Underperform
    Expects underperformance against the local market by 10% or more over next 12 months.

Dresdner Kleinwort Benson

  • Strong Buy
  • Buy
  • Hold
  • Reduce
  • Sell

Dundee Securities

Edward Jones

Emerging Growth Equities

FAC/Equities

  • Strong Buy
  • Buy
  • Neutral
  • Underperform

FTN Financial Securities

  • Outperform
    15% upside in place upon initiation or upgrade.
  • Neutral
    Less than 15% upside or downside in place upon initiation or upgrade/downgrade.
  • Underperform
    15% downside in place upon initiation or downgrade.

Fahnestock & Co.

  • Buy
    Anticipates appreciation of 10% or more within the next 12 months, and/or a total return of 10% including dividend payments, and/or the ability of the shares to perform better than the leading stock market averages or stocks within its particular industry sector.
  • Neutral
    Anticipates stock will trade at or near current price and generally in line with leading market averages due to perceived absence of strong dynamics that would cause volatility either to upside or downside, and/or will perform less well than higher rated companies within its peer group.
  • Sell
    Anticipates stock will depreciate 10% or more in price within the next 12 months due to fundamental weakness perceived in co. or for valuation reasons, or are expected to perform significantly worse than equities within its peer group.

Ferris Baker Watts

  • Buy
    One factor must be positive or two positives if there is one negative.
  • Hold
    All categories neutral, or positives and negatives balanced.
  • Sell
    All four categories negative or negative fundamental developments that imply questionable intrinsic value.

Factors on which ratings are based are intrinsic value; relative value; capital flow/market sentiment; and fundamental catalyst.

First Analysis

  • Overweight
    Stock expected to perform better than the broad market over next 12 months.
  • Equal-weight
    Stock price expected to perform in line with broad market over next 12 months.
  • Underweight
    Stock expected to perform worse than broad market over next 12 months.

Fox-Pitt Kelton

  • Outperform
    Expects stock to outperform the sector over next 12 months.
  • In line
    Expects stock to perform in line with its sector over next 12 months.
  • Underperform
    Expects stock to underperform its sector over next 12 months.

Friedman Billings Ramsey

  • Outperform
    Expects co. will outperform similar companies within its industry over next 12 months. Recommends investors buy securities at current valuation.
  • Market Perform
    Expects co. will perform in line with similar companies within its industry. Recommends investors maintain current positions and add on weakness as valuation or fundamentals become more favorable.
  • Underperform
    Expects co. will underperform similar companies within its industry. Recommends investors reduce their positions until valuation or fundamentals become more compelling.

Frost Securities

  • Strong Buy
    25 percent-plus absolute total return or 15 percent-plus relative outperformance over next 9-12 months
  • Buy
    15 percent-plus total return, 10 percent-plus relative outperformance over next 9-12 months, or stocks with strong buy potential returns but earnings visibility too limited to justify strong buy rating
  • Market Perform
    Minus-10 percent to plus-10 percent relative return in-line with the market over the next 9-12 months
  • Market Underperform
    Absolute return 0 percent to minus-20 percent relative underperformance over next 9-12 months

Gerard Klauer Mattison

  • Buy
  • Outperform
  • Neutral
  • Underperform

Goldman Sachs

  • Recommended List
    Expected to provide price gains of at least 10 percentage points greater than the market over next 6-18 months.
  • Latin America Recommended List
    Expected to provide price gains at least 10 percentage points greater than the Latin America MSCI Index over next 6-18 months.
  • Trading Buy
    Expected to provide price gains of at least 20 percentage points sometime in the next 6-9 months.
  • Market Outperformer
    Expected to provide price gains of at least 5-10 percentage points greater than the market over next 6-18 months.
  • Market Performer
    Expected to provide price gains similar to the market over next 6-18 months.
  • Market Underperformer
    Expected to provide price gains of at least 5 percentage points less than the market over next 6-18 months.

H.C. Wainwright

  • Strong Buy
  • Buy
  • Hold
  • Sell
  • Monitor

Hibernia Southcoast Capital

Ratings represent time frame of within 12 months.

  • Buy
    Stocks deemed to have potential to achieve minimum 15% upside to current price.
  • Hold
    Stocks that are deemed to have greater amount of risk and/or less timely price appreciation potential.
  • Sell
    Stocks where a negative return is expected

Investec

  • Buy
    Expected 12-month absolute performance of +20% or greater from the price at the time the rating was initiated.
  • Hold
    Expected 12-month absolute performance of +20% to -20% from the price at the time the rating was initiated.
  • Sell
    Expected 12-month absolute performance of -20% or less from the price at the time the rating was initiated.

J. Michael-Patrick

J.P. Morgan H&Q

  • Overweight
    Expects stock to outperform average total return of stocks in analyst's or analyst's team's coverage universe over next 6-12 months.
  • Neutral
    Expects stock to perform in line with the average total return of stocks in analyst's o r analyst's team's coverage universe over next 6-12 months.
  • Underweight
    Expects stock to underperform the average total return of stocks in the analyst's or analyst's team's coverage universe over next 6-12 months.

Janney Montgomery Scott

  • Strong Buy
  • Buy
  • Accumulate
  • Hold
  • Sell

Jefferies & Co.

  • Buy
    Expected to appreciate by 20% or more. Stock's total return expected to exceed the average total return of the analyst's industry coverage universe, on a risk-adjusted basis, over the next 12 months.
  • Accumulate
    Expected to appreciate by 10-20%.
  • Hold
    Expected to change plus or minus 10%. Stock's total return is expected to be in line with the average total return of the analyst's industry coverage universe, on a risk-adjusted basis, over the next 12 months.
  • Sell
    Expected to decline by more than 10%. Stock's total return is expected to be below the average total return of the analyst's industry coverage universe, on a risk-adjusted basis, over the next 12 months.
  • NR
    Investment rating and target price, if any, have been suspended temporarily.

Johnson Rice & Co.

  • Buy
  • Accumulate
  • Hold
  • Funds Source
  • Sell

JMP Partners

  • Strong Buy
    Expects stock price to appreciate 20 percent or more on absolute basis over next 6 months
  • Market Outperform
    Expect stock price to outperform relevant market indices over next 12 months
  • Market Perform
    Expect stock price to perform in -line with relevant market indices over next 12 months
  • Market Underperform
    Expect stock price to underperform relevant mark indices over next 12 months
  • Sell
    View stock as source of funds

Kaufman Bros.

  • Buy
    Expects stock to outperform its peer group over next 12 months due to superior fundamentals, low valuation and/or positive catalysts
  • Hold
    Expects stock to perform in line with peer group over next 12 months due to full valuation and/or lack of catalysts
  • Sell
    Expects stock to underperform its peer group over next 12 months due to deteriorating fundamentals overvaluation and/or negative catalysts

Kempen & Co.

Ladenburg Thalmann

  • Buy
    Expected total return of at least 10% greater than the market over next 12-18 months.
  • Market Perform
    Expected total return at or near +/-10% of the market over the next 12-18 months.
  • Sell
    Expected total return of more than -10% of the market over next 12-18 months.

Lazard Freres

Leerink Swann & Co.

  • Outperform
    Expects stock to outperform its benchmark by more than 10 percentage points over next 12 months.
  • Market Perform
    Expects stock to perform within a range of plus or minus 10 percentage points of its benchmark over next 12 months.
  • Underperform
    Expects stock to underperform its benchmark by more than 10 percentage points over next 12 months.

Legg Mason

  • Buy
    Expects stock to outperform the S&P 500 by more than 10% over next 12 months. For higher-yielding equities such as REITs and utilities, expects total return in excess of 12% over next 12 months.
  • Hold
    Expects stock to perform within +/-10% of the S&P 500 over next 12-months. Also used for higher yielding securities where there is comfort with safety of the dividend but believe upside in share price is limited.
  • Sell
    Expected to underperform the S&P 500 by more than 10 percent over next 12 months and believes stock could decline in value.

Risk ratings of Low, Average and High are also assigned to stocks based primarily on strength of balance sheet and predictability of earnings.

Lehman Bros.

  • Overweight
    Stock is expected to outperform the weighted total return of the industry sector over a 12-month investment horizon.
  • Equal-Weight
    Stock is expected to perform in line with the unweighted total return of the industry sector over a 12-month investment horizon.
  • Underweight
    Stock is expected to underperform the unweighted expected total return of the industry sector over a 12-month investment horizon.
  • Rating Suspended
    Rating and target price have been suspended temporarily to comply with applicable regulations and/or firm policies in certain circumstances including when Lehman Bros. is acting in an advisory capacity on a merger or strategic transaction involving the company.

Sectors are rated either positive where sector fundamentals are improving; neutral where sector fundamentals are steady, neither improving nor deteriorating; or negative where sector fundamentals are deteriorating.

Loop Capital Markets

  • Industry Significant Outperform
    Company will perform in excess of 30%.
  • Industry Outperform
    Company will perform by greater than 10% but below 30%.
  • Industry Perform
    Company will perform within +/-10% of the benchmark.
  • Industry Underperform
    Company will underperform by more than 10% but less then 30%.
  • Industry Significant Underperform
    Company will underperform by more than 30%.

McAdams Wright Ragen

  • Buy
    Expects stock to outperform the market.
  • Hold
    Expects stock to be a market performer.
  • Sell
    Expects stock to underperform the market.

Mercury Partners

  • Buy
    Risk adjusted, 12-month total return estimated to be above 12%.
  • Hold
    Risk adjusted, 12-month total return estimated between 5% and 12%.
  • Sell
    Risk adjusted, 12-month total return estimated to be 5% or less.

Merrill Lynch

  • Buy
    Expected total return of 10% or more for low and medium volatility risk securities within 12-month period from date of initial rating; 20% or more for high volatility risk securities.
  • Neutral
    0-10% expected total return for low and medium volatility risk securities within 12-month period from initial date of rating; 0-20% for high volatility risk securities.
  • Sell
    Negative return.

Midwest Research

Moors & Cabot

Morgan Lewins & Co.

  • Buy
    Reasonable outperformance relative to the market over 12-18 months.
  • Hold
    Market-type risk adjusted performance; potential source of funds.
  • Sell
    Expected to underperform the market.

Morgan Stanley

  • Overweight
    Stock's total return is expected to exceed the average total return of the analyst's industry coverage universe, on a risk-adjusted basis, over next 12-18 months.
  • Equal-weight
    Stock's total return is expected to be in line with the average total return of the analyst's industry coverage universe, on a risk-adjusted basis, over next 12-18 months.
  • Underweight
    Stock's total return is expected to be below the average total return of the analyst's industry coverage universe, on a risk-adjusted basis, over next 12-18 months.
  • More Volatile
    Estimates stock has more than 25% chance of price move up or down of more than 25% in a month, based on a quantitative assessment of historical data. Or, in analyst's view, is likely to become materially more volatile over next 1-12 months compared with past 3 years. Stocks with less than one year of trading history are automatically rated as more volatile unless otherwise noted.

National Bank Financial

Needham & Co.

  • Strong Buy
    A security, which at the time the rating is instituted, indicates an expectation of a total return of at least 50 percent over the next 12-18 months.
  • Buy
    A security, which at the time the rating is instituted, indicates an expectation of a total return of between 20 percent and 50 percent over the next 12-18 months.
  • Hold
    A security, which at the time the rating is instituted, indicates a total return of +/-20 percent over next 12-18 months.
  • Sell
    A security, which at the time the rating is instituted, indicates an expectation that the price will depreciate by more than 20 percent over the next 12-18 months.

Oscar Gruss

  • Buy
    Expected total annual return of greater than 20 percent
  • Speculative Buy
    Expected total annual return of greater than 25 percent if anticipated contingencies materialize over next 12-18 months, with potential for high return volatility and greater than average risk for lower or negative total annual returns in this time period
  • Outperform
    Expected total annual return in the range of 10 percent-20 percent
  • Hold
    Stock appears to be fairly valued and may provide returns which approximate returns expected from its peer group in the equity markets
  • Sell
    Stock appears overvalued or is experiencing problems that may cause it to underperform peer group

Other factors considered in ratings may include but are not limited to the company's risk profile including earnings predictability, financial position, industry position, technology and product risks, management strengths and other factors

Pacific Crest

Pacific Growth Equities

  • Overweight
    Stock's total return is expected to exceed the average total return of the analyst's industry coverage universe, on a risk-adjusted basis, over the next 12-18 months.
  • Equal Weight
    Stock's total return is expected to be in line with the average total return of the analyst's industry coverage universe, on a risk-adjusted basis, over the next 12-18 months.
  • Under Weight
    Stock's total return is expected to be below the average total return of the analyst's industry coverage universe, on a risk-adjusted basis, over the next 12-18 months.

PMG Capital

  • Strong Buy
  • Buy
  • Long-Term Buy
  • Hold

Prudential

  • Buy
    Expected to appreciate a minimum of 20 percent viewed on total return basis over 12-month time horizon.
  • Hold
    All other stocks
  • Sell
    Expected to depreciate a minimum of 20 percent viewed on total return basis over 12-month time horizon.

Putnam Lovell

RBC Capital Markets

  • Top Pick
    A subset of outperform rated companies representing the best in the outperform category; an analyst's best ideas; expected to significantly outperform the sector over 12 months; provides very best risk-reward ratio; represents about 10 percent of each analyst's recommendations.
  • Outperform
    Expected to materially outperform the sector average over 12 months.
  • Sector Perform
    Returns expected to be in line with sector average over 12 months.
  • Underperform
    Returns expected to be materially below the sector average over 12 months.

All recommendations also include risk qualifiers of either above average, average and speculative.

RTX Securities

  • Strong Buy
    Outperform market in near-term; initiate full position now
  • Buy
    Outperform market over next 12 months; begin or add to position
  • Market Perform
    Perform in line with market over next 12 months; hold position
  • Reduce
    Underperform market over next 12 months; lighten position
  • Sell
    Underperform market in near-term; sell entire position

Ragen MacKenzie

  • Strong Buy
  • Buy
  • Accumulate
  • Market Perform

Raymond James

  • Strong Buy
    Stock is expected to appreciate and produce a total return of at least 15 percent and outperform the S&P 500 over the next six months.
  • Outperform
    Stock is expected to appreciate and outperform the S&P 500 over the next 12 months.
  • Market Perform
    Stock is expected to perform generally in line with the S&P 500 over the next 12 months and is potentially a source of funds for more highly rated securities.
  • Underperform
    Stock is expected to underperform the S&P 500 or its sector over the next 6-12 months and should be sold.

Research Capital

  • Buy
  • Accumulate
  • Hold
  • Reduce

Robert W. Baird

  • Outperform
    Expected to outperform on a total return, risk-adjusted basis the broader U.S. equity market over the next 12 months.
  • Neutral
    Expected to perform in line with the broader U.S. equity market over the next 12 months.
  • Underperform
    Expected to underperform on a total return, risk-adjusted basis the broader U.S. equity market over the next 12-months.

Risk ratings of Lower, Average, Higher and Speculative also apply.

Roth Capital Partners

SG Cowen

  • Strong Buy
    Stock expected to outperform the market by over 25% over 12-month horizon.
  • Buy
    Stock expected to outperform the market by 10-25% over 12-month horizon.
  • Market Perform
    Stock expected to out/underperform the market by +/-10% over 12-month horizon.
  • Underperform
    Stock Expected to underperform the market by at least 10% over 12-month horizon.

Salomon Smith Barney

  • Outperform
    Stock is projected to outperform analyst's industry coverage universe over the coming 12-18 months.
  • In-Line
    Stock is projected to perform approximately in line with analyst's industry coverage universe.
  • Underperform
    Stock is projected to underperform analyst's industry coverage universe over the coming 12-18 months.

Industries are rated relative to the primary market index in each region as either overweight: Expected to perform better than primary market index for region in next 12-18 months; marketweight: Expected to perform about in line with the primary market index for the region in the next 12-18 months; or underweight: Expected to perform worse than the primary market index for the region in the next 12-18 months. Stocks also carry risk ratings of either low, medium high, or speculative.

Sandler O'Neill

  • Buy
    Stock is materially undervalued and represents and attractive investment candidate. Stock expected to appreciate more than 10% within next 12 months.
  • Maintain
    Stock is either fairly valued or modestly undervalued, is expected to appreciate between 0 and 10% within next 12 months.
  • Reduce
    Stock is overvalued and could decline in value within next 12 months. Potential price decline could be of any magnitude and is quantified by analyst's price target.

Sands Brothers

  • Strong Buy
  • Buy
  • Neutral
  • Sell

Sanford Bernstein

  • Outperform
    Stock will outpace the market index by more than 15 percentage points in the year ahead.
  • Market Perform
    Stock will perform in line with the market index to within +/- 15 percentage points in the year ahead.
  • Underperform
    Stock will trail the performance of the market index by more than 15 percentage points in the year ahead.

Seidler Cos.

  • Strong Buy
    Greater than 20% return vs. market within next 6-12 months.
  • Buy
    Strong long-term fundamentals, expect positive return over next 12-18 months.
  • Hold
    Declining business fundamentals, limited visibility.
  • Sell
    Poor fundamentals, expect significant downside to stock over next 12 months.

Sidoti & Co.

  • Buy
    Suggests capital appreciation of at least 25% over the next 12 months.
  • Neutral
    Stock not likely to provide similar gains over a 12- month period.

SoundView Technology Group

  • Outperform
    Expect stock to outperform SoundView 100 benchmark by more than 10 percentage points over next 6-12 months
  • Neutral
    Expect stock to perform within a range of +/-10 percentage points of the SoundView 100 benchmark over next 6-12 months

Spencer Clarke

  • Strong Buy
  • Buy
  • Neutral
  • Sell

Stephens Inc.

  • Overweight
    Stock's total return is expected to be greater than the total return of the company's industry sector, on a risk adjusted basis, over the next 12 months.
  • Equal-Weight
    Stock's total return is expected to be equivalent to the total return of the company's industry sector, on a risk-adjusted basis, over the next 12 months.
  • Underweight
    Stock's total return is expected to be less than the total return of the company's industry sector, on a risk-adjusted basis, over the next 12 months.
  • Volatile
    Stock's price volatility is potentially higher than that of the company's industry sector.

Recommendations are made within the broader context of an industry rating. Industry fundamentals are rated either improving, stable or deteriorating.

Sterling Research

Stifel Nicolaus

  • Strong Buy
    Stock is expected to achieve a total return of 20% or more, to outperform the S&P 500 and to outperform its industry peers over the next 12-18 months.
  • Buy
    Stock is expected to achieve total return of 15% or more and to outperform the S&P 500 over the next 12-18 months.
  • Market Perform
    Stock is expected to perform generally in line with the S&P 500 over the next 12-18 months and is potentially a source of funds for investor clients.
  • Market Underperform
    Stock is expected to lose 10% or more in total return, to underperform the S&P 500 and to underperform its industry peers over the next 12-18 months. The security should be sold if such sale is consistent with clients' needs and objectives.

SunTrust Robinson-Humphrey

  • Overweight
    Stock's total return is expected to exceed the unweighted average return of the analyst's industry group over the next 12 months.
  • Equal Weight
    Stock's total return is expected to be in line with unweighted average return of analyst's industry group over the next 12 months.
  • Underweight
    Stock's total return is expected to be below the unweighted average return of the analyst's industry group over the next 12 months.

Stocks are also assigned a risk rank based on combination of fundamental and stock volatility factors of either Low, Moderate, High, Speculative or Venture.

Sutro & Co.

  • Strong Buy
  • Buy
  • Accumulate
  • Hold

SWS Securities

  • Strong Buy
    Fundamentals of company and industry are strong and stock has an attractive valuation. Expects 20 percent or higher return over next 12 months.
  • Market Outperform
    Good company but short-term price volatility expected. Expects stock performance to exceed average historical market return, but appreciate less than 20 percent over next 12 months.
  • Neutral
    Stock is fairly valued. There is no compelling reason to buy or sell the stock today. Is cautious about short-term prospects for industry/company.
  • Sell
    Fundamentals of industry and/or company are deteriorating. Doesn't expect company to have consistent earnings growth over next 12-24 months or business model is questionable. Expects 20 percent or more stock price depreciation.

Think Equity Partners

  • Overweight
    Expected outperform the unweighted expected total return of the analyst's universe over a 12-month investment horizon.
  • Equal Weight
    Expected to perform in-line with the unweighted expected total return of analyst's universe over a 12-month investment horizon.
  • Underweight
    Expected to underperform the unweighted expected total return of the analyst's universe over a 12-month investment horizon.

Thomas Weisel Partners

  • Strong Buy
    Among the best ideas under coverage at the firm. Stock is mispriced relative to business prospects and/or other names in the sector. Expect a near-term catalyst to drive valuation higher
  • Buy
    Solid business prospects and/or attractive valuation should cause the stock to outperform the market. A near-term catalyst may exist
  • Market Perform
    Solid business prospects should cause the common stock to perform in line with stocks of similar potential/risk.
  • Underperform
    Stock is fundamentally overpriced. Valuation is highly likely to fall in the short-term

Tucker Anthony

  • Strong Buy
  • Buy
  • Market Perform

UBS Warburg

  • Strong Buy
    Greater than 20% excess return potential; high degree of confidence.
  • Buy
    Positive excess return potential.
  • Hold
    Low excess return potential; low degree of confidence.
  • Reduce
    Negative excess return potential.
  • Sell
    Greater than 20% negative excess return potential; high degree of confidence.

USB Piper Jaffray

  • Strong Buy
    Expected to significantly outperform relevant broader market index over next 6 to 12 months. An identifiable catalyst is present to drive appreciation.
  • Outperform
    Expected to outperform the relevant broader market index over next 12 to 18 months.
  • Market Perform
    Expected to perform in line with relevant broader market index over next 6 to 12 months.
  • Underperform
    Expected to underperform the relevant broader market index over next 6 to 12 months.

WR Hambrecht & Co.

  • Buy
    Stocks recommended for active buying, are expected in absolute dollar terms to appreciate at least 10 percent over the next 6 months.
  • Hold
    Stocks would continue to hold in portfolio, are expected to appreciate or depreciate in absolute dollar terms less than 10 percent over the next 6 months.
  • Sell
    Stocks recommended for active selling, are expected to depreciate in absolute dollar terms at least 10 percent over the next 6 months.

Wachovia Securities

  • Strong Buy
    Believe substantial/meaningful upside potential exists. Has high visibility on estimates and confidence in co.'s business model and management's execution abilities. A near-term catalyst should be able to drive stock higher. Buy aggressively.
  • Buy
    Believes stock is attractively valued. Co. has sound or improving fundamentals that should allow it to outperform broader market. Buy.
  • Hold
    Believes stock is fairly valued at current price. Co. may have issues affecting fundamentals that could take some time to resolve. Alternatively, fundamentals may be sound but this is fully reflected in stock price. Do not accumulate additional shares.
  • Sell
    Believes stock is overpriced relative to soundness of co.'s fundamentals and long-term prospects. Co. has significantly weak fundamentals or flawed business model. Sell.

Wasserstein Perella

Wedbush Morgan

  • Strong Buy
  • Buy
  • Long-Term Attractive
  • Hold
  • Sell

Wells Fargo Securities

  • Buy
    Immediate purchase is recommended. Stock is expected to outperform the general market over next 12-18 months.
  • Hold
    Holding the stock is recommended. Stock has moved out of preferred buying range, but there is further upside to share price or stated objectives at time of purchase have changed and share appreciation may take another 6-12 months.
  • Sell
    Stock has reached stated price objective and appreciation has been achieved or certain company fundamentals have changed warranting investors sell the stock to avoid price decline.

Whale Securities

William Blair & Co.

  • Outperform
    Expects stock to outperform the broader market over next 12 months.
  • Market Perform
    Expects stock to perform approximately in line with the broader market over next 12 months.
  • Underperform
    Expects stock to underperform broader market over next 12 months.

Williams Capital

  • Strong Buy
    Reflects potential estimated total return of 20% within the next 12-18 months for a stock with average risk; 15% for a stock with low risk; and 35% for a stock with high risk.
  • Buy
    Reflects potential estimated total return of 15% within the next 12-18 months for a stock with average risk; 10% for a stock with low risk; and 25% for a stock with high risk.
  • Hold
    Reflects potential estimated return of 10% within the next 12-18 months for a stock with average risk; 5% for a stock with low risk; and 20% for a stock with high risk.
  • Reduce
    Reflects potential estimated total return of 5% within the next 12-18 months for a stock with average risk; -10% for a stock with low risk; and 15% for a stock with high risk.
  • Sell
    Reflects potential estimated total return of -10% within the next 12-18 months for a stock with average risk; -15 percent for a stock with low risk; and 10% for a stock with high risk.

Yorkton Securities

  • Top Pick
  • Buy
  • Accumulate
  • Hold
  • Reduce
  • Sell

Mon, 17 Aug 2020 10:14:00 -0500 en text/html https://www.marketwatch.com/tools/guide.asp Killexams : Stock Analyst Update

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

Fri, 17 Feb 2023 10:00:00 -0600 en text/html https://www.morningstar.com/collections/181/stock-analyst-update
Killexams : Revenue Analyst: Job Description and Average Salary

A revenue analyst is a special type of accountant who keeps track of a company's revenue and looks for ways to Boost it. This analysis is multifaceted. The revenue analyst tracks revenue over time and determines the direction of the trend. He determines how a company's revenue compares to competitors in the industry. The analyst breaks down revenue by individual product and service and determines which goods are making the company money and which are not. He matches revenues to expenses for each business segment to determine the relative profitability of each segment. A revenue analyst must possess an almost preternatural attention to detail and be highly accurate with his work.

Key Takeaways

  • Revenue analysts are similar to accountants.
  • A revenue analyst is responsible for managing a company's revenue and helping make business decisions to Boost it.
  • Revenue analysts should be comfortable with math.

Revenue Analyst Job Duties

Revenue analysts are responsible for taking large sets of numerical data and extracting from them valuable information about the company's revenue that management can use to make business decisions. The amount of specialization for a revenue analyst varies from position to position, with large companies often employing more specialized analysts and smaller companies hiring fewer analysts but training them on the entire breadth of the field.

Some revenue analysts take a micro approach to analyzing data. In other words, they draw conclusions from examining strictly company data. Their reports are minimally influenced by external forces or broader economic data. For this type of revenue analyst, common job duties include matching revenues to expenses for various business segments; tracking the revenues of a company product or service, or for the company as a whole, over time and charting the trend; and brainstorming potential ways to increase revenue without affecting a concomitant increase in expenses.

For example, a revenue analyst tasked with examining internal data for a retail operation might track revenue over time for various products. Additionally, he might match revenues to expenses to determine the relative profitability of each product. Beyond number crunching and ascertaining trends and profit margins, a revenue analyst must also be capable of taking the information he has uncovered and formatting it into financial reports that are easy to read and easy to understand. After all, it is the members of the company management team, many of whom do not have the strong math or accounting background of a revenue analyst, and who rely on the data to make business decisions. The revenue analyst offers valuable information derived from often-complex quantitative analysis, but he must present this information to his superiors in a way that makes sense to a layperson.

Other revenue analysts incorporate macro data into their analyses. Apart from internal data, these analysts draw conclusions based on economic data from outside the company, such as industry trends, competitor data, and economic indicators. For example, without looking at external data, it can be easy to falsely conclude that a slight downward trend in revenue results from poor management or misguided business decisions. One duty of a revenue analyst is to control for external factors when examining data. Therefore, if a slight drop in revenue coincides with an even larger drop in broader economic indicators, an alternative and likely more accurate conclusion is that management is doing just fine; it is mitigating losses in the face of a challenging economy.

Skills

Revenue analysis is a challenging job that is highly rewarding for those who possess the right skill set. A revenue analyst is a type of accountant. Like all accountants, revenue analysts should be good with numbers. For most positions in the industry, advanced math skills, such as high-level calculus, are not required. However, a revenue analyst should be quantitatively inclined and in no way intimidated by math.

Attention to detail is paramount for a revenue analyst. The job entails working with large data sets and it is easy to get confused. Even tiny mistakes in the analysis process can lead to misguided conclusions, which render an analyst's financial reports inaccurate. This can result in management making bad decisions based on faulty data.

Though accountants carry a stereotype of introversion and solitude, people skills are vital for a revenue analyst. Most of them work in teams. They eventually come together to compile their findings into one unified report, particularly at large companies where revenue analysts specialize. Moreover, a common career path for a revenue analyst is to start as a team member and then be promoted to team leader. Even with strong technical skills and numerical proficiency, making that jump is difficult without good people skills.

Education Required

While no rigid educational requirements exist for revenue analysts, most companies hiring for the position want to see at least a bachelor's degree, preferably in accounting, finance, economics or statistics. In the modern job market, revenue analysts without college degrees are few and far between; graduating college should be viewed as a de facto requirement.

Many companies, particularly large firms, prefer to hire certified public accountants (CPAs) for revenue analyst positions. Becoming a CPA requires minimum education hours, passing an exam and then working under an existing CPA for a period of time. To take the exam, a candidate must first complete 150 hours of postsecondary education. This is more than a bachelor's degree but just short of a master's degree. Firms often hire revenue analysts who have completed the required education but who have not taken the exam, under the contingency, they complete the exam within a certain period, usually one year, of their hire date. These professionals are known as CPA candidates since their education qualifies them to take the steps to become CPAs.

Average Salary

Revenue analysts make an average of $52,000 per year. Someone new to the field can expect to earn between $34,000 and $75,000. Where an employee fits in this range depends on several factors, including geographic location, company size, and individual performance. Beyond the pay, another benefit to this career is nearly unlimited upward mobility. Revenue analysts regularly get promoted to revenue manager, controller, vice president and even chief financial officer (CFO). Revenue analysts also report high levels of job satisfaction. They tend to work reasonable hours and enjoy generous benefits, such as health care coverage and paid time off.

Mon, 21 Dec 2015 04:16:00 -0600 en text/html https://www.investopedia.com/articles/professionals/011116/revenue-analyst-job-description-average-salary.asp
Killexams : Analyst Stock Picks Fri, 17 Feb 2023 01:50:00 -0600 en text/html https://www.cnbc.com/pro/analyst-stock-picks/ Killexams : How To Become A Financial Analyst: Requirements And Job Outlook

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations.

For anyone with a mind for business, a big-picture outlook and strong communication skills, becoming a financial analyst may be a promising career path. Financial analysts can work in a variety of industries studying economic trends, making predictions and offering recommendations for investments and other money moves.

Most financial analyst jobs require at least a bachelor’s degree. After gaining some work experience, financial analysts can increase their prospects through licenses and certifications. Our guide explores more details about how to become a financial analyst.

Southern New Hampshire University

Elevate your career to the next level with a comprehensive and flexible MBA program from Southern New Hampshire University

Learn More

What Do Financial Analysts Do?

In general terms, financial analysts do exactly what their title implies: They advise companies and individuals on the most profitable investments. These professionals must be able to distill large amounts of information into concise recommendations.

Financial analysts assess whether a company is worth investing in by poring through the company’s financial history. These professionals may also help companies decide how to invest in growing industries. Financial analysts are responsible for studying economic, political and global trends to make recommendations.

While financial analysts need a broad understanding of the market, they aren’t expected to know everything. Analysts tend to focus on one industry, region or product, and they build expertise in their specialty area.

Work Environment

Financial analysts don’t just work with securities. They may be employed by companies to analyze other types of investment, such as real estate or marketing dollars. Analysts may even work for media or research companies. Rather than advising clients on profitable investments, these workers analyze trends and publish their findings or predictions.

Types of Financial Analysts

Several job titles fall under the financial analyst umbrella, as noted by the U.S. Bureau of Labor Statistics (BLS). Below we list a few examples.

  • Financial risk analysts make investment decisions that limit potential losses.
  • Ratings analysts assess whether companies (or governments) can pay their debts.
  • Portfolio managers determine the mix of investments in their clients’ portfolios, and they answer to stakeholders.
  • Fund managers—who work with hedge funds or mutual funds—and portfolio managers both make buy-and-sell decisions to maximize returns.

What Skills Do Financial Analysts Need?

Financial analysts should, of course, have analytical minds and be detail-oriented in their research. They need both strong math skills and computer literacy, as analysts use software to look at trends and make forecasts.

After all of their research, financial analysts need to make decisions. Their recommendations can affect a company’s longevity, so they must be thorough but decisive. Analysts have to communicate their choices clearly and effectively, often through reports or presentations.

How Much Does a Financial Analyst Make?

Becoming a financial analyst is a strong option for anyone seeking a higher-than-average paycheck. As of May 2021, the median annual wage for financial analysts was $91,580, according to the BLS. In contrast, the median wage for all workers was $45,760.

Working as an analyst in the financial industry offers the most lucrative pay. These workers earn a mean annual salary of $124,020.

Job Outlook

The field is also growing at a steady pace. The BLS projects employment for financial and investment analysts to grow by 9% from 2021 to 2031, which is faster than the average projected growth for all jobs. This amounts to about 32,000 new financial analyst jobs by 2031.

As you may guess, increases in economic activity affect the demand for financial analysts. Expanding and emerging industries require the help of financial analysts to guide their growth.

Globalization is a factor as well. As more markets develop around the world, companies need analysts to advise on where to expand or invest. The BLS predicts that these investors will hire financial analysts who have a deep understanding of political, economic and cultural trends in the geographical areas at play.

Buy-Side Analysts vs. Sell-Side Analysts

Financial analysts—not including those who work for research and media companies—fall into two main categories: buy-side analysts and sell-side analysts.

Buy-Side

Buy-side analysts help companies choose where to invest. These companies, known as institutional investors, include pension funds, hedge funds, money managers and insurance companies. This category also encompasses nonprofit groups with endowments, which are large donations that have been invested to increase the original cash value.

Most financial analysts are on the buy side. While they don’t perform any stock transactions themselves, they advise companies on the most profitable investments. This may involve actual securities, real estate or even franchise opportunities. Employers may also have analysts look at their business practices, marketing spending or other returns on investment.

Sell-Side

Sell-side analysts, on the other hand, advise agents who sell securities or other investments. This is a much narrower field than buy-side. Research analysts, for example, analyze companies’ financial data and create reports that recommend whether to buy, sell or hold those stocks. They also flag trends on individual stocks within fund portfolios.

As the CFA Institute notes, one of the pressures on sell-side analysts is that they are responsible for accurate stock ratings. Their findings are used by buy-side analysts to make decisions, and those ratings carry a lot of weight within the industry.

Note that financial analysts aren’t responsible for actually buying or selling any investments. Instead, these professionals must rely on strong data analysis and communication skills to persuade stakeholders to carry out their recommendations.

How to Become a Financial Analyst

Financial Analyst Education Requirements

Most firms require candidates to have at least a bachelor’s degree. The CFA Institute recommends a finance-related major such as a bachelor’s degree in accounting, finance, statistics, economics or general business.

While most employers don’t require a master’s degree, this advanced degree may help analysts move up to the next stage of their careers. With a proven track record, a financial analyst can advance to a role as a portfolio manager or a fund manager for wealthy individual investors. An MBA can demonstrate an analyst’s communication and business knowledge.

Financial Analyst Certification

Entry-level licenses for financial analysts are available from the Financial Industry Regulatory Authority (FINRA). FINRA regulates the securities industry and offers dozens of exams for various job types. Most of these exams require employer sponsorship.

In most cases, financial analysts must pass the Securities Industry Essentials® exam, which covers basic information about the industry. General securities representatives must pass the Series 7 exam.

After gaining some work experience, analysts may pursue the Chartered Financial Analyst (CFA) charter, administered by the CFA Institute.

CFA candidates must have a bachelor’s degree or be within 11 months of completing one. If not, they should have a significant amount of work and/or higher education experience over at least three years. They also need an international passport, a few professional references and 4,000 hours of qualifying work experience.

Take note that the CFA charter isn’t an easy course—it requires more than 900 hours of individual study, on top of professional work hours. Prospective CFAs must also complete three levels of exams before they can apply to become charterholders.

Frequently Asked Questions (FAQs) About Financial Analysts

What are the top three skills for a financial analyst?

Financial analysts must be detail-oriented and analytical because each recommendation can have a significant impact on their employer or the market as a whole. They also need math and computer skills to help them synthesize data and come to a conclusion. Communication skills are just as important.

What qualifications do I need to be a financial analyst?

To become a financial analyst, you should earn a bachelor’s degree in a subject related to finance, such as business, economics or statistics. Once hired, you will probably need to pass qualification exams through FINRA to begin practicing.

Is a financial analyst the same as an accountant?

No. Both roles deal with finances, but in very different ways. Accountants work with their company’s finances on a day-to-day level, while analysts look at overall economic trends and make recommendations for the most profitable investments.

How long does it take to become a financial analyst?

You can become a financial analyst within four years, or the time it takes you to earn a bachelor’s degree. Depending on the type of work you plan to do, it may take additional time to earn licensure through FINRA as well.

Wed, 15 Feb 2023 17:08:00 -0600 Kayla Missman en-US text/html https://www.forbes.com/advisor/education/become-a-financial-analyst/
Killexams : Data Analysis Tools Market Management of Massive Data and Availability to Hamper the Industry Growth

The MarketWatch News Department was not involved in the creation of this content.

Feb 06, 2023 (The Expresswire) -- The Data Analysis Tools Market report with massive business opportunities in the industry structure, sales (consumption), production, Generate Revenue at Significant Rate, capacity, statics figure and gross margin. The industry production status, market share, status and company profile of the manufacturers [, MATLAB, Cluvio, Looker, XLSTAT, Google Analytics, Domo, WebFOCUS, GoodData, IBM Cognos Analytics, SpotIQ, Toucan Toco, Stata, Sisense, Minitab, NVivo, Clootrack, Qlik Sense, Visitor Analytics, CheckPOS Performance, Zoho Analytics, QueryStorm, Birst, Yellowfin,] are presented. Primary and secondary research is conducted on Data Analysis Tools companies to obtain the latest government regulations, market information and industry data. Data Analysis Tools market Data were collected from the manufacturers, product types [, Cloud, On-Premise, ,], end users [, BFSI, Healthcare, IT and Telecom, Energy and Power, Retail, Manufacturing, Education, Government, Media and Entertainment, Others,], distributors, governments' industry bureaus, industry associations, industry experts, third party database, industry publications, and our in-house databases.

According to 360 Market Updates (360marketupdates.com) this latest study, the 2023 development of Third-Party Replacement Strap for Data Analysis Tools market will have huge change from earlier year.

To Know How Covid-19 Pandemic and Russia Ukraine War Will Impact This Market

"Powerful new research technologies introduce Detailed TOC of Data Analysis Tools Market report [107 Pages Report], Tables and Figures with Charts that provides exclusive data that generate revenue, vital statistics figures, and competitive landscape details in this ICT sector.

How Big is the Global Data Analysis Tools market?

Data Analysis Tools Report Coverage:This part incorporates brief data about key items sold in the wide-reaching Data Analysis Tools market followed by an outline of significant fragments and makers canvassed in the report. It additionally gives features of market size development paces of various sort and application segments. Moreover, it incorporates data about concentrate on targets and years considered for the total research study of 107 Pages report.

Who is the Top Data Analysis Tools Manufacturer of the Industry?

Top Key Industry Players:Leading Top players of the industry are profiled here on the basis of economic activity and plans, products, Revenue, SWOT analysis, production, and other manufacturing details. Data Analysis Tools Market Size by Manufacturer,in this report, mergers and acquisitions and price, revenue, and expansion plans, are analysed.

Companies Covered in this report are:

● MATLAB ● Cluvio ● Looker ● XLSTAT ● Google Analytics ● Domo ● WebFOCUS ● GoodData ● IBM Cognos Analytics ● SpotIQ ● Toucan Toco ● Stata ● Sisense ● Minitab ● NVivo ● Clootrack ● Qlik Sense ● Visitor Analytics ● CheckPOS Performance ● Zoho Analytics ● QueryStorm ● Birst ● Yellowfin ●

Get a trial PDF of the Report @https://www.360marketupdates.com/enquiry/request-sample/20314275#utm_source=MWjohnss

What is the Scope of Data Analysis Tools Market?

Short Summary:Here, the report focuses on key trends of various products and other markets. It also shares analysis of the competitive landscape, where prominent key players and market concentration ratio are shed light upon. Players are studied on the basis of their date of market entry, manufacturing base distribution, products, and headquarters.

Data Analysis Tools Marketsize, segment (mainly coveringMajorType (, Cloud, On-Premise, ,),End Users (, BFSI, Healthcare, IT and Telecom, Energy and Power, Retail, Manufacturing, Education, Government, Media and Entertainment, Others,), and regions), latest status, development trendsa and competitor landscape. Furthermore, the 107 pages report provides detailed cost analysis, supply chain.

Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream end users. Also, Consumer behaviour analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Data Analysis Tools market.

Which Region is Expected to Hold the Highest Market Share 2022 to 2029?

Production by Region:Apart from global production and revenue shares by region, the authors have shared critical information about regional production in different geographical markets. Each regional market is analysed taking into account vital factors, viz. import and export, key players, and revenue, besides production. ● Primary Data Analysis Tools Market Consumption by Global Region:The report concentrates on global and regional consumption here. It provides figures related to global consumption by region such as consumption market share. All of the regional markets studied are assessed on the basis of consumption by country and application followed by analysis of country-level markets.

Which is the Leading Segment in the Data Analysis Tools Market?

By Type:It includes analysis of price, revenue, and production by type ({, Cloud, On-Premise, ,}. ● By Application:It gives an overview of market size analysis by application followed by analysis of consumption market share, consumption, and breakdown data by application {, BFSI, Healthcare, IT and Telecom, Energy and Power, Retail, Manufacturing, Education, Government, Media and Entertainment, Others,}. ● Entry Strategy for Key Countries:Entry strategies for all of the country-level markets studied in the report are provided here.

Request A Special trial Copy of the Data Analysis Tools Market Report

What is the Key Factor Driving the Market?

Production Forecasts:It includes forecast of key producers, where important regions and countries are taken into consideration, followed by forecast by type. Apart from global production and revenue forecasts, this section provides production and revenue forecasts by region. ● Consumption Forecast:It includes global consumption forecast by application and region. In addition, it provides consumption forecast for all regional markets studied in the report.

It also discussions about the market size of different segments and their growth aspects along with Competitive benchmarking, Historical data and forecasts, Company revenue shares, regional opportunities, Latest trends and dynamics, growth trends, various stakeholders like investors, CEOs, traders, suppliers, Research and media, Global Manager, Director, President, SWOT analysis i.e., Strength, Weakness, Opportunities and Threat to the organization and others. Revenue forecast, company share, competitive landscape, growth factors and trends.

Inquire more and share questions if any before the purchase on thishttps://www.360marketupdates.com/enquiry/pre-order-enquiry/20314275#utm_source=MWjohnss

Detailed TOC of Global Data Analysis Tools Market Research Report 2022

1 Data Analysis Tools Market Overview

1.1 Product Overview and Scope of Data Analysis Tools
1.2 Data Analysis Tools Segment by Type
1.2.1 Global Data Analysis Tools Market Size Growth Rate Analysis by Type 2022 VS 2029
1.3 Data Analysis Tools Segment by Application
1.3.1 Global Data Analysis Tools Consumption Comparison by Application: 2022 VS 2029
1.4 Global Market Growth Prospects
1.4.1 Global Data Analysis Tools Revenue Estimates and Forecasts (2015-2029)
1.4.2 Global Data Analysis Tools Production Capacity Estimates and Forecasts (2015-2029)
1.4.3 Global Data Analysis Tools Production Estimates and Forecasts (2015-2029)

2 Market Competition by Manufacturers
2.1 Global Data Analysis Tools Production Capacity Market Share by Manufacturers (2015-2022)
2.2 Global Data Analysis Tools Revenue Market Share by Manufacturers (2015-2022)
2.3 Data Analysis Tools Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Data Analysis Tools Average Price by Manufacturers (2015-2022)
2.5 Manufacturers Data Analysis Tools Production Sites, Area Served, Product Types
2.6 Data Analysis Tools Market Competitive Situation and Trends
2.6.1 Data Analysis Tools Market Concentration Rate
2.6.2 Global 5 and 10 Largest Data Analysis Tools Players Market Share by Revenue
2.6.3 Mergers and Acquisitions, Expansion

3 Production Capacity by Region
3.1 Global Production Capacity of Data Analysis Tools Market Share by Region (2015-2022)
3.2 Global Data Analysis Tools Revenue Market Share by Region (2015-2022)
3.3 Global Data Analysis Tools Production Capacity, Revenue, Price and Gross Margin (2015-2022)

4 Global Data Analysis Tools Consumption by Region
4.1 Global Data Analysis Tools Consumption by Region
4.1.1 Global Data Analysis Tools Consumption by Region
4.1.2 Global Data Analysis Tools Consumption Market Share by Region
4.2 North America
4.3 Europe
4.4 Asia Pacific
4.5 Latin America

Get a trial Copy of the Data Analysis Tools Market Report 2023

5 Segment by Type
5.1 Global Data Analysis Tools Production Market Share by Type (2015-2022)
5.2 Global Data Analysis Tools Revenue Market Share by Type (2015-2022)
5.3 Global Data Analysis Tools Price by Type (2015-2022)
6 Segment by Application
6.1 Global Data Analysis Tools Production Market Share by Application (2015-2022)
6.2 Global Data Analysis Tools Revenue Market Share by Application (2015-2022)
6.3 Global Data Analysis Tools Price by Application (2015-2022)

7 Key Companies Profiled
7.1 Company
7.1.1 Data Analysis Tools Corporation Information
7.1.2 Data Analysis Tools Product Portfolio
7.1. CData Analysis Tools Production Capacity, Revenue, Price and Gross Margin (2015-2022)
7.1.4 Company’s Main Business and Markets Served
7.1.5 Company’s latest Developments/Updates

8 Data Analysis Tools Manufacturing Cost Analysis
8.1 Data Analysis Tools Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Data Analysis Tools
8.4 Data Analysis Tools Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Data Analysis Tools Distributors List
9.3 Data Analysis Tools Customers

10 Market Dynamics
10.1 Data Analysis Tools Industry Trends
10.2 Data Analysis Tools Market Drivers
10.3 Data Analysis Tools Market Challenges
10.4 Data Analysis Tools Market Restraints

11 Production and Supply Forecast
11.1 Global Forecasted Production of Data Analysis Tools by Region (2023-2029)
11.2 North America Data Analysis Tools Production, Revenue Forecast (2023-2029)
11.3 Europe Data Analysis Tools Production, Revenue Forecast (2023-2029)
11.4 China Data Analysis Tools Production, Revenue Forecast (2023-2029)
11.5 Japan Data Analysis Tools Production, Revenue Forecast (2023-2029)

12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Data Analysis Tools
12.2 North America Forecasted Consumption of Data Analysis Tools by Country
12.3 Europe Market Forecasted Consumption of Data Analysis Tools by Country
12.4 Asia Pacific Market Forecasted Consumption of Data Analysis Tools by Region
12.5 Latin America Forecasted Consumption of Data Analysis Tools by Country

13 Forecast by Type and by Application (2023-2029)
13.1 Global Production, Revenue and Price Forecast by Type (2023-2029)
13.1.1 Global Forecasted Production of Data Analysis Tools by Type (2023-2029)
13.1.2 Global Forecasted Revenue of Data Analysis Tools by Type (2023-2029)
13.1.3 Global Forecasted Price of Data Analysis Tools by Type (2023-2029)
13.2 Global Forecasted Consumption of Data Analysis Tools by Application (2023-2029)
13.2.1 Global Forecasted Production of Data Analysis Tools by Application (2023-2029)
13.2.2 Global Forecasted Revenue of Data Analysis Tools by Application (2023-2029)
13.2.3 Global Forecasted Price of Data Analysis Tools by Application (2023-2029)

14 Research Finding and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

Continued….

Purchase this report (Price USD 2980 for a single-user license) @https://www.360marketupdates.com/purchase/20314275#utm_source=MWjohnss

Contact Us:

360 market updates

Phone:USA: +1 424 253 0807

UK: +44 203 239 8187

Email: sales@360marketupdates.com

Web: https://www.360marketupdates.com/

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Data Analysis Tools Market Management of Massive Data and Availability to Hamper the Industry Growth

COMTEX_423979012/2598/2023-02-06T21:25:49

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Mon, 06 Feb 2023 11:25:00 -0600 en-US text/html https://www.marketwatch.com/press-release/data-analysis-tools-market-management-of-massive-data-and-availability-to-hamper-the-industry-growth-2023-02-06
Killexams : CSX Stock (NASDAQ:CSX), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Sat, 18 Feb 2023 02:11:00 -0600 en text/html https://www.benzinga.com/quote/CSX/analyst-ratings
COG-300 exam dump and training guide direct download
Training Exams List